Patents by Inventor Kenneth Thirstrup

Kenneth Thirstrup has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240390357
    Abstract: The present invention relates to pyridines and their use for increasing GBA activity and/or levels as well as treatment of GBA-related diseases, such as Parkinson's disease.
    Type: Application
    Filed: September 27, 2022
    Publication date: November 28, 2024
    Inventors: Søren NEVE, William Dalby BROWN, Kenneth THIRSTRUP
  • Publication number: 20240390383
    Abstract: The present invention relates to dioxazines, their synthesis, and their use for increasing GBA activity and/or levels as well as treatment of GBA-related diseases, such as Parkinson's disease.
    Type: Application
    Filed: September 27, 2022
    Publication date: November 28, 2024
    Inventors: Søren NEVE, William Dalby BROWN, Kenneth THIRSTRUP
  • Publication number: 20240383853
    Abstract: The present invention relates to oximes, their synthesis, and their use for increasing GBA activity and/or levels as well as treatment of GBA-related diseases, such as Parkinson's disease.
    Type: Application
    Filed: September 27, 2022
    Publication date: November 21, 2024
    Inventors: Søren NEVE, William Dalby BROWN, Kenneth THIRSTRUP
  • Publication number: 20040259777
    Abstract: The present invention relates generally to the control of metabolic disorders, such as body weight disorders, of animals including mammals and humans, and more particularly to polypeptides identified herein as modulators of metabolic disorders, and to diagnostic and therapeutic uses of such modulators. In its broadest aspect, the present invention relates to mammalian neuronatin proteins sequences, isoforms thereof, and degenerate variations thereof, that demonstrate the ability to participate in the control of mammalian metabolism and that have been postulated to play a critical role in the regulation of body weight, adiposity and non-insulin dependent diabetes mellitus (NIDDM). The invention further relates to the preparation of the modulators of the invention.
    Type: Application
    Filed: December 4, 2003
    Publication date: December 23, 2004
    Inventors: Kenneth Thirstrup, Jens Damsgaard Mikkelsen, Niels Vrang, Leif Kongskov Larsen, Mads Tang-Christensen
  • Publication number: 20040171008
    Abstract: The invention relates to G-protein coupled receptor (GPCR) arrays, methods for production of GPCR arrays, primers used in the production of GPCR arrays and kits containing GPCR arrays and further to the use of such GPCR arrays in methods for the determination of expression profiles in biological materials in which there is an interest in the expression of GPCR polynucleotides.
    Type: Application
    Filed: November 12, 2003
    Publication date: September 2, 2004
    Inventors: Kenneth Thirstrup, Lars Siim Madsen, Jens Bitsch Jensen, Rene Hummel, Bo Skaaning Jensen
  • Patent number: 6706476
    Abstract: This invention relates to a method wherein special adaptors and primers are used for single stranded cDNA amplification. The method comprises contacting RNA with an anchored cDNA synthesis primer which can anneal to RNA, a suitable enzyme which possesses reverse transcriptase activity, and a special designed adaptor which can efficiently be ligated to the 3′ end of single stranded cDNA by T4 DNA ligase. Processes are provided for using specific primers annealing to the adaptors in the 5′ and 3′-end of the single stranded cDNA for PCR amplifying the cDNA. The invention describes the use of this approach for generation of probes starting from low amounts of RNA to be used e.g. in hybridization towards micro-arrays.
    Type: Grant
    Filed: March 9, 2001
    Date of Patent: March 16, 2004
    Assignee: Azign Bioscience A/S
    Inventors: Kenneth Thirstrup, Peter Warthoe, Niels Bo Pettersson